Square Enix approves arbitrum for symbiogenesis chapter 2

User Avatar

Square Enix recently announced the adoption of Ethereum Layer-2 network Arbitrum for its Symbiogenesis NFT character coin scheduled to launch this morning.

The decision comes after the first coin phase on the Ethereum mainnet. According to an X-post from Symbiogenesis, Arbitrum will significantly reduce transaction fees compared to Ethereum’s mainnet, at about 1/1000 of the previous fees.

The game previously used Polygon, an Ethereum sidechain, for other in-game NFT assets and it is unclear whether Polygon will continue to be used for future assets alongside Arbitrum.

symbiogenesis-day-1-coin
symbiogenesis-day-1-coin Source: Symbiogenesis

Symbiogenesis’ first day of sales

Symbiogenesis, a story-driven game that intertwines character NFTs and in-game items, offers an exclusive narrative experience only accessible to owners of specific character NFTs. The game aims to release a total of 10,000 characters.

In December, the game released its first 500 characters on Ethereum and is currently trading at less than 0.12 $ETH (or about $452) on secondary marketplaces.

Today marks the launch of another 1,500 new NFT characters on Arbitrum, starting with a public auction that will run for three days through Sunday. At the time of writing, Symbiogenesis has confirmed that NFT character sales have completely sold out for the first day of the auction.

For the latest updates on Symbiogenesis, follow the official X or visit the official website.

Want more? Connect with NFT Plazas

Sign up for the weekly newsletter
Join our Telegram
follow us on twitter
Like us on Facebook
Follow us on Instagram

*All investment/financial opinions expressed by NFT Plazas are from the personal research and experience of our site moderators and are intended as educational materials only. Individuals are required to fully research any product before making any form of investment.

See also  'Universal Page' marketplace emerges for next-generation gasless NFTs



Source link

Share This Article
Leave a comment